Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Potassium citrate 3g/10mL mixture BP (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium citrate 3g/sachet granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium citrate 12g/10mL concentrated mixture (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq/15mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium gluconate 20meq/15mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 1g/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 1g/5mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq/15m solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10 meq750 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 750mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing potassium chloride 20 mEq/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 15meq |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 1.875 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium bicarbonate 25meq |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq/pkg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 15meq/pkg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing potassium chloride 8 mEq/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10meq m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 750 mg10 meq tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 1.5 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 1.5g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq/pkt solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 1500mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 750 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 1.5 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 8meq |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium bicarbonate 2.5 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing potassium chloride 10 mEq/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium citrate 540 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium citrate 1.08 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq/10mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citric acid + potassium citrate + sodium citrate 334mg/550mg/500mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citric acid monohydrate + potassium citrate + sodium citrate 334mg/550mg/500mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citric acid monohydrate + potassium citrate + sodium citrate 334mg/550mg/500mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citric acid monohydrate + potassium citrate + sodium citrate dihydrate 334mg/550mg/500mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citric acid monohydrate + potassium citrate 334mg/1100mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citric acid monohydrate + potassium citrate 334mg/1100mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medicinal product acting as potassium supplement (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium citrate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium supplement therapy (regime/therapy) |
Direct substance |
True |
Potassium supplement |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |